Skip to main content
Harris Gelbard, MD, Child Neurology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

HarrisAGelbardMDPhD

Child Neurology • Rochester, NY

Director, Center for Neural Development and Disease

Join to view full profile

Dr. Gelbard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gelbard's full profile

Already have an account?

Education & Training

  • Children's Hospital/Beth Israel Deaconess Medical Center/Harvard Medical School
    Children's Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Child Neurology, 1985 - 1988
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1983 - 1985
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1983
  • Northwestern University Graduate School
    Northwestern University Graduate SchoolPh.D., 1983
  • Northwestern University Settlement Association
    Northwestern University Settlement AssociationBS, Honors Program in Medical Education, 1976

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1989 - 2025
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

  • Awardee of the Hilary Koprowski Prize in Neurovirology Drexel University College of Medicine, 2016
  • Inaugural Awardee of the Translational Research in NeuroVirology Lectureship International Society for Neurovirology, 2015
  • 585 Magazine Castle Connolly, 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Behavioral Deficits at 18-22 Months of Age Are Associated with Early Cerebellar Injury and Cognitive and Language Performance in Children Born Extremely Preterm  
    Duncan AF, Bann CM, Dempsey A, Peralta-Carcelen M, Hintz S, Gelbard HA, J Pediatr, 1/3/2018
  • Long acting slow effective release antiretroviral therapy  
    Edagwa B, McMillan JE, Sillman B, Gendelman HE, Gelbard HA, Expert Opin Drug Deliv, 1/14/2017
  • Platelet-activating factor receptors mediate excitatory post-synaptic hippocampal injury in experimental autoimmune encephalomyelitis  
    Bellizzi MJ, Geathers J, Allan K, Gelbard HA, J. Neurosci., 1/27/2016
  • Join now to see all

Books/Book Chapters

  • Encyclopedia of AIDS 
    Chapter: HAND adjunctive therapies: reversing neuronal injury. 
    Marker DF, Fitzgerald, T and Gelbard HAEditors: Hope, TJ, Stevenson, M, and Richman, D.Springer Science + Business Media, New York2015
  • Microglia in Health and Disease 
    Chapter: Human immunodeficiency virus. 
    Page 373 - 392Marker DF, Lu S-M and Gelbard HAEditors: Tremblay M� and Sierra A.Springer Science + Business Media, New York2014
  • The Neurology of AIDS 
    Chapter: Development of Adjunctive Therapies for the Neurological Manifestations of AIDS: HAND and Painful Neuropathy. 
    Gelbard HA and Lipton SAEditors: Everall, Fox, Gelbard, Grant, Lipton, Swindells and Gendelman.Oxford Press, New YorkEdition 3rd,2012
  • Join now to see all

Lectures

  • "Broad spectrum inhibition of mixed lineage kinases: Roles for URMC-099 in NASH, persistent HIV-1 infection and HAND." 
    Lianyungang, China - 1/1/2018
  • "The development of URMC-099, a broad spectrum mixed kinase inhibitor for the treatment of non-alcoholic steatohepatitis." 
    China - 1/1/2018
  • "Selectively non-selective inhibition of innate immunity: A role for URMC-099 in CRISPR/Cas9-based HIV-1 cure strategies." 
    Philadelphia, PA - 1/1/2018
  • Join now to see all

Other

  • Multi-target drugs should be in the pharma pipeline along with precision drugs. 
    Harris A. Gelbard, Statnews
    1/31/2019
  • Mixed Lineage Kinase Inhibitors for HIV/AIDS Therapies. 
    HA Gelbard, S Dewhurst and H Gendelman, China Patent #ZL201380060736.1.
    1/10/2018
  • Mixed Lineage Kinase Inhibitors and Method of Treatments. 
    VS Goodfellow, T Nguyen, SB Ravula and HA Gelbard, United States Patent #9,370,515
    1/21/2016
  • Join now to see all

Press Mentions

  • Multi-Target Drugs Should Be in the Pharma Pipeline Along with Precision Drugs
    Multi-Target Drugs Should Be in the Pharma Pipeline Along with Precision DrugsJanuary 31st, 2019
  • Scientists Find Cause of Cognitive Decline in MS Patients
    Scientists Find Cause of Cognitive Decline in MS PatientsJanuary 27th, 2016
  • Coming Soon: HIV Shots?
    Coming Soon: HIV Shots?November 4th, 2015
  • Join now to see all

Grant Support

  • Platelet Activating Factor, Synaptic Failure &NeuroaidsNational Institute Of Mental Health2005–2012
  • Project 3National Institute Of Mental Health2010–2011
  • Project 2National Institute Of Mental Health2010–2011
  • Project 1National Institute Of Mental Health2010–2011
  • Core ANational Institute Of Mental Health2010–2011
  • Novel Adjunctive Therapies For NeuroaidsNational Institute Of Mental Health2006–2011
  • Administrative CoreNational Institute Of Mental Health2009
  • The Axon-Oligodendrocyte Precursor Synapse In NeuroaidsNational Institute Of Mental Health2008–2009
  • Targeted Neuro Protection Of HIV-1 Associated Neurologic DiseaseNational Institute Of Mental Health2007–2009
  • Novel HIV TherapiesNational Institute Of Mental Health2006–2009
  • Endogenous Mechanisms Of NeuroprotectionNational Institute Of Mental Health2006–2009
  • Core--Drug Design For The Molecular Target MLK-3National Institute Of Mental Health2006–2009
  • Core--Cell And Molecular Core FacilityNational Institute Of Mental Health2006–2009
  • Core--Biostatistics And Data ManagementNational Institute Of Mental Health2006–2009
  • Photoconductive Stimulation Of Synapses And HIV NeurotoxinsNational Institute Of Mental Health2006–2008
  • Influence Of Glia On Neuronal Function In HIV Infection In VitroNational Institute Of Neurological Disorders And Stroke2003–2007
  • Targeted Neuro Protection Of HIV-1 Associated NeurologicNational Institute Of Mental Health2006
  • In Vitro Cell Models Of NeuroaidsNational Institute Of Mental Health2004–2005
  • Targeted Neuroprotection For HIV-1 Associated DementiaNational Institute Of Mental Health2001–2005
  • Role Of PAF In HIV-1 NeuropathogenesisNational Institute Of Mental Health2000–2003
  • HIV 1 And CNS Inflammation: Prelude To ParkinsonismNational Institute Of Mental Health2001–2002
  • Strategies To Prevent Oxidative Stress In CNS AIDSNational Institute Of Mental Health1999–2000
  • Platelet Activating Factor And HIV-1 DementiaNational Institute Of Mental Health1996–1999
  • Strategies To Prevent Oxidative Stress In CNS AIDSNational Institute Of Mental Health1997–1998
  • Dopamine Receptor Systems After Early Brain InjuryNational Institute Of Neurological Disorders And Stroke1992–1996

Hospital Affiliations

Dr. Harris Gelbard, Dr. Harris Gelbard, MD, Dr. H Gelbard, Dr. Harris A Gelbard